RIVAXORED (Rivaroxaban) 10 mg Tablets Bioequivalence: Bioequivalent to the innovator (Xarelto®) — comparative bioavailability data on file. Description: Oral factor Xa inhibitor (anticoagulant). Uses: Prevents VTE after hip or knee replacement; extended prevention of recurrent DVT/PE after ≥6 months of treatment. Ingredients: Rivaroxaban 10 mg (film-coated tablet). How to use: 10 mg once daily, starting 6–10 hours after surgery when bleeding is controlled; duration per surgeon’s advice. With or without food. Precautions (key only): Bleeding risk—seek urgent care for unusual/ongoing bleeding or signs of internal bleeding. Do not use with hepatic disease causing coagulopathy. Prescriber will consider renal function and interacting medicines. Prescription medicine.
KES 540.00
Delivery within 4 hours on all orders placed between 8:00 AM & 8:00 PM
Facebook
WhatsApp
Twitter